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Psoriasis is a common in£ammatory skin disease that is
thought to be mediated by activated T cells. In this
study, the complementarity-determining region 3
(CDR3) inTcell receptors was examined for a common
sequence motif among the Tcells in¢ltrated in psoriatic
lesional skin. A common speci¢c CDR3 motif (Vb13-
DWTSGV-Jb2.7) in lesions from psoriasis patients was
identi¢ed by polymerase-chain-reaction-based spectra-
typing analysis and DNA sequencing. In addition, VDJ
rearrangement with highly homologous amino acid
composition in the CDR3 was observed in Vb15 of T
cell receptors in lesions derived from psoriatic patients.
Remarkably, T cell receptors containing the Vb13-
DWTSGV-Jb2.7 were also found in the clinically nor-
mal skin from the psoriasis patients, which might seem
to be responsible for the arti¢cial production of psoria-
tic lesions. The identi¢ed CDR3 motif was highly ex-
pressed in cutaneous lymphocyte antigen (CLAþ ) cells
of peripheral blood mononuclear cells from psoriasis
patients compared with the expression in healthy indi-
viduals. This result showed that the in¢ltrated CLAþ T
cells with the Vb13-DWTSGV-Jb2.7 motif in peripheral
blood mononuclear cells from psoriasis patients might
be involved in the development of psoriatic lesions. In
addition, the results in this study suggest that the in¢l-
trated T cells with the Vb13-DWTSGV-Jb2.7 motif in
psoriatic lesions may be involved in the pathogenesis of
psoriasis. Key words: complementary determining region 3/
psoriasis/Tcell receptor. J Invest Dermatol 120:359 ^364, 2003
P
soriasis is a common chronic in£ammatory skin disease
characterized by hyperproliferation of keratinocytes
and in¢ltration of macrophages, neutrophils, and
monocytes (Bos and De Rie, 1999). Psoriasis is asso-
ciated with strong hereditary components, which
involve particular human leukocyte antigen (HLA) alleles such
as Cw6, B13, BW53, and DRB1n07 (Kim et al, 2000; Elder et al,
2001). Although the exact pathogenesis of psoriasis remains to be
elucidated, it is likely to be mediated by activated T cells, and
furthermore the cytokines released from the activated T cells en-
hance proliferation of keratinocytes (Schlaak et al, 1994; Yawalkar
et al, 1998; Ohta et al, 2001). The current hypothesis is that defects
in T cell regulation are primarily responsible for psoriasis (Prinz,
1999). The observation that T cells are a major e¡ector in psoriasis
resulted in new therapeutic approaches. T cell immunosuppres-
sants (cyclosporine A and FK506), the use of a modi¢ed interleu-
kin-2-based lymphocyte-selective toxin, or blockage of T cell
costimulation with cytotoxic T-lymphocyte-associated antigen
4-immunoglobulin have been found to be e¡ective in diminish-
ing psoriatic symptoms. Accordingly, it is important to under-
stand the nature of T cell responses in psoriasis for deciphering
its pathogenesis (Gottlieb et al, 1995; Bagel et al, 1998; Abrams
et al, 2000). Activation of T cells is caused by recognition of
complexes of peptide and major histocompatibility complex by
means of the T cell receptor (TCR). The TCR is composed of
heterodimers, ab-dimers, or gd-dimers. Each subunit of the
TCR is composed of V (variable), D (diversity), J (joining), and
C (constant) regions encoded in gene segments that rearrange
to form the ¢nal product. During the rearrangement process, a
variable number of bases can be deleted from or added to the
V and J segments or between the V, D, and J segments. The
addition or deletion of nucleotides in this region de¢nes the
diversity of the complementarity determining region 3 (CDR3),
and this is implicated in the speci¢city of antigen recognition.
Within CDR3, the gene segments encoding the hypervariable
VDJ region of the TCR b-chain are reported to be major
determinants for antigen recognition. In general,T cell lines with
identical peptide speci¢city would share conserved CDR3 amino
acid sequence motifs (Davis and Bjorkman, 1988; Casanova
and Maryanski, 1993). In this regard, identi¢cation of CDR3
within TCR has been useful to determine speci¢c antigens.
Therefore,TCR usage analysis has been widely used as a ¢rst step
to identify speci¢c CDR3 regions (Gorski et al, 1994). Several re-
ports have shown the existence of clonally expanded T cells or of
highly repetitive TCR usage on psoriatic lesions, which suggests
that psoriasis may be an antigen-speci¢cTcell response. The anti-
gen that can drive activation of T cells is not yet identi¢ed, how-
ever (Chang et al, 1994; Prinz et al, 1999). Identi¢cation of
common CDR3 motifs among T cells from psoriatic lesions
would help in understandingT cell recognition to a speci¢c anti-
gen(s) and its potential association with the disease initiation and
progress. This would also lead to development of a useful TCR
marker for psoriasis with eventual contribution to new therapeu-
tic approaches. Accordingly, this study was performed to identify
a common CDR3 motif of T cells in¢ltrated in lesions from
psoriasis patients.
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MATERIALS AND METHODS
Skin biopsies and preparation of peripheral blood mononuclear
cells (PBMC) Six 2 mm punch skin biopsies were taken from psoriatic
lesions located on the back, arm, or abdomen and from nonlesional skin of
each of 28 psoriasis patients who visited the outpatients clinic. Biopsies
from nonlesional skin that looked normal were taken at least 5 cm distant
from lesional skin, and skin biopsies were also taken from eight healthy
individuals. Blood samples were obtained from 12 psoriasis patients and
six healthy individuals. Then, PBMC were isolated from heparinized
blood by density centrifugation using Ficoll-Hypaque (Sigma, St. Louis,
MO).
Puri¢cation of cutaneous lymphocyte antigen (CLAþ ) cells from
PBMC CLAþ cells were puri¢ed from PBMC of ¢ve psoriasis patients
and three healthy individuals by the magnetic cell sorting method. Brie£y,
1107 PBMC were incubated with 50 ml of £uorescein isothiocyanate
(FITC) conjugated CLA antibody (BD Pharmingen, San Diego, CA) at
41C for 15 min, washed with phosphate-bu¡ered saline (PBS) three times,
and resuspended in 50 ml of PBS. Then, 50 ml of anti-FITC microbeads
(Miltenyi Biotech, Bergisch Gladbach, Germany) were added and the
samples were incubated at 41C for 15 min, washed, and resuspended in
500 ml of PBS. The resuspended samples were loaded on a MACS LSþ
column (Miltenyi Biotech) using a magnetic ¢eld. After applying the
sample, the column was washed with PBS three times and removed from
the magnetic ¢eld; the CLAþ cells were eluted from the column with PBS.
Preparation of total RNA and analysis of TCR Vb gene
rearrangement by reverse transcription polymerase chain reaction
(RT-PCR) Skin biopsies and PBMC were homogenized in Trizol
reagent (Life Technologies, Grand Island, NY). After homogenization,
total RNA was isolated according to the manufacturer’s instructions and
resuspended in 20 ml of diethyl-pyrocarbonate-treated water. Then,
isolated RNA was reverse transcribed into ¢rst strand cDNA using an
oligo-dT primer and Moloney murine leukemia virus reverse transcriptase
(Life Technologies). cDNA was subjected to PCRwith glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) as internal control and PCR was
carried out for 25 cycles. Then, cDNA, which was normalized by
GAPDH, was used in the ¢rst round PCR with a 30 TCR b-chain
constant region (TCR Cb) primer designated as Cb3 (50 -
ctcttgaccatggccatc-30) in conjunction with 26 di¡erent 50 TCR b-chain variable
region (TCRVb) gene family primers, whose sequences corresponded to
those described by Gorski et al (1994). The ampli¢cation pro¢le was 30 s at
941C for denaturation, 30 s at 581C for annealing, and 45 s at 72.51C for
extension in a total of 23 cycles. The second round PCRwas performed
with 0.5 ml of the ¢rst round PCR product, the 50 primer of the same Vb
gene families, and the 30 primer of Cb5 (internal primer of constant
region, 50 -agatctctgcttctgatggctc-30) in the same conditions for a total of
25 cycles. The ampli¢ed PCR products were separated and analyzed on a
1.3% agarose gel.
CDR3 size spectratyping, cloning, and sequencing of the TCR Vb
CDR3 region of in¢ltrating T cells on psoriatic lesions cDNAwas
¢rst ampli¢ed withVbCb primer pairs, and 1 ml of the ¢rst round PCR
product was used in the second round ampli¢cation with reverse Cb5
primer and 32P-labeled forward Vb primer. Radioactive PCR products
were mixed with equal volumes of denaturing bu¡er and heated at 951C
for 5 min. Five microliters of the samples were loaded onto a 6%
sequencing gel for size fractionation depending on the size of the CDR3
region as described previously (Gorski et al, 1994) and were analyzed after
exposure to X-ray ¢lm (Kodak, Rochester, NY). In particular, in the case
of the TCRVb CDR3 region using Vb13 and Vb15, the PCR products
visualized on the ¢lm as individual bands were cut and reampli¢ed (30
cycles) with appropriate primer sets. The resulting PCR products were
cloned into pGEM-T easy vector (Promega, Madison, WI) and then
sequenced with the Sequenase kit (USB, Cleveland, OH) using the
method of dideoxy-chain termination (Sanger et al, 1977).
Detection of the TCRVb CDR3 region with the identi¢ed CDR3-
speci¢c oligonucleotide The oligonucleotide corresponding to the
identi¢ed CDR3 sequence (50 -gattggactagcggggtctacgagt-30) was syn-
thesized (Bioneer, Daejeon, Korea) and subsequently labeled with 32P-ATP
(Amersham and Pharmacia Biotech, Buckinghamshire, U.K.) using T4
kinase (Life Technologies) according to the manufacturer’s instructions.
The labeled CDR3-speci¢c oligonucleotide probe was used to trace
similar or identical sequences and the radiolabeled Cb5 oligonucleotide
probe was used to trace the Cb expression as an internal control in each
cDNA sample.
cDNA that was normalized by GAPDH was used for ¢rst round PCR
with 50 Vb forward primer and 30 Cb3 primer. Second round PCRwas
carried out with 50 CDR3-speci¢c oligonucleotide and 30 Cb3 primer
to detect the CDR3 region, and also using 50 Cb2 (50 -ccgaggtcg
ctgtgtttgagccat-30) and 30 Cb3 reverse primer as internal control. The
second round PCR products were separated on 1.3% agarose gel,
transferred to a positively charged nylon membrane (Schleicher & Schuell,
Dassel, Germany) by capillary action, and covalently ¢xed to the
membrane by ultraviolet cross-linker (Spectolinker, Westbury, NY). The
cross-linked nylon membranes were prehybridized at 421C for at least 3 h
in 6 sodium chloride sodium phosphate EDTA, 1% sodium dodecyl
sulfate (SDS), 10Denhardt’s solution, 20 mg per ml yeast tRNA, and 50
mg per ml salmon sperm DNA. Hybridization was performed at 441C (for
the Cb5 probe) and 561C (for the CDR3-speci¢c probe) in a hybridization
solution (6 SSPE, 1% SDS, 10Denhardt’s solution, 20 mg per ml yeast
tRNA, and 50 mg per ml salmon sperm DNA) containing the labeled
probe overnight according to the manufacturer’s recommendation
(Schleicher & Schuell) with some modi¢cations. After washing at 511C
for the Cb5 probe and 631C for the CDR3-speci¢c probe in 0.1SSPE
and 1% SDS, the membrane was exposed on X-ray ¢lm. The exposed
¢lms were scanned and analyzed by densitometer (ImageMaster VDS,
Amersham and Pharmacia Biotech) and the optical density was
determined. The expression levels of the CDR3 motif relative to those of
the constant region of the TCR b-chain (Cb) were calculated and the
results were expressed as a ratio.
RESULTS
TCR b-chain rearrangement in psoriatic lesions TCRVDJ
rearrangements were analyzed in biopsies from lesional and
nonlesional skin from six psoriasis patients for the ¢rst time.
cDNA was ampli¢ed by PCR using a Cb-speci¢c primer
together with each one of 26 di¡erent primers speci¢c for the
Vb gene families and subfamilies, Vb1^24. Of the 26 Vb gene
families,TCRVb13 expansion on psoriatic lesions was observed in
four patients (patients 1, 2, 5, 6) and TCR Vb15 in ¢ve patients
(patients 1, 2, 3, 5, 6) of six patients examined (Fig 1). Except for
Vb13 and Vb15, expressions of Vb8 (patients 1, 4) and Vb22
(patients 1, 2, 5) were increased on psoriatic lesions (data not shown).
CDR3 analysis of Vb13 and Vb15 of TCR on psoriatic
lesions To understand better the TCR repertoire in the
expanded T cells on lesions from psoriasis patients, the CDR3
regions of TCR Vb13 and Vb15 were analyzed using PCR-
based spectratyping. The CDR3 spectratypes on psoriatic
lesions showed a Gaussian distribution, indicating a typical
heterogeneous distribution of CDR3 size among the bulk T
cells in the psoriatic lesions. Although di¡erences were noted in
the pattern of each patient, no markedly skewed pattern in the
CDR3 spectrum was detected (data not shown). To analyze the
Figure1. RT-PCR analysis of expression of TCR b-chain. Total
RNA from skin biopsies from six psoriasis patients was reverse transcribed
to cDNA. cDNA, which was normalized with GAPDH, was used for the
¢rst round PCRwith Vb-speci¢c primer and Cb3 primer in a total of 23
cycles. The second round PCRwith 0.5 ml of the ¢rst round PCR product,
Vb-speci¢c primer, and Cb5 primer (internal primer of constant region)
was carried out for 25 cycles. The PCR products were analyzed on a 1.3%
agarose gel. N means nonlesional skin and L means lesional skin from
psoriasis patients. Arrows in right size indicate the real PCR products.
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Table I. TCRVDJ region sequences of the in¢ltrating Tcells withVb13 in the psoriatic lesions from six patients
Patient Vb13 region (N)D(N) J region Constant region Nomenclature and frequency
Patient 1 SVYFCASS RKFTLLG NQPQHSGDGTRLSIL EDLNKVFPPE Jb1.5 (8/35)
ETGALLANT GYTFGSGTRLTVV Jb1.2 (1/35)
YASGI AKNIQYFGAGDPLSVL Jb2.4 (2/35)
HEGLP SYNEQFFGPGTRLRVL Jb2.1 (2/35)
YSLFGG KNIQYFGAGTRLSVL Jb2.4 (1/35)
SVYFCASR DWTSGV YEQYFGPGTRLTVT Jb2.7 (1/35)
WGSK NTGELFFGEGSRLTVL Jb2.2 (3/35)
YERGLYEQYFGPGRRLTVT Jb2.7 (3/35)
YGF SGNTIYFGEGTWLTVV Jb1.3 (1/35)
TGDGG YEQYFGPGTRLTVT Jb2.7 (3/35)
SQGHP YGYTFGSGTRLTVV Jb1.2 (2/35)
PWGGAD TEAFGQGTRLTVV Jb1.1 (1/35)
PRGGWGYTAGSGTRLTVV Jb1.2 (7/35)
Patient 2 AKFTLVGNG QPQHFGDGTRLSIL Jb1.5 (2/35)
RRPPGQGMTG ELFFGEGSRLTVL Jb2.2 (1/35)
YASGI AKNIQYFGPGTRLTVL Jb2.4 (6/35)
YSKVGAYNEQFFGPGTRLTVL Jb2.1 (1/35)
DWTSGV YEQYFGPGTRLTVT Jb2.7 (2/35)
GGGQR NTEAFFGQGTRLTVV Jb1.5 (1/35)
SVYFCASR(S) ELAHLT YEQYFGPGTRLTVT Jb2.7 (1/35)
PGGID NQPQHFGDGTRLSIL Jb1.5 (4/35)
ELAHLT YEQYFGPGTRLTVT Jb2.7 (1/35)
RPGQVLS EQYFGPGTRLTVT Jb2.7 (1/35)
EGPGAEYE QYFGPGTRLTVT Jb2.7 (1/35)
LSKGIQ QPQHFGDGTRLSIL Jb1.5 (2/35)
YGF SGNTIYFGEGSWLTVV Jb1.3 (1/35)
ADRF SYEQYFGPGTRLTVT Jb2.7 (5/35)
YERGF YEQYFGPGTRLTVT Jb2.7 (1/35)
YGF SGNTIYFGEGSWLTVV DHNKVFPPE Jb1.3 (4/35)
PRGGWGYTFGSGTRLTVV Jb1.2 (1/35)
Patient 3 AKETLVG NQPQHFGDGTRLSIL Jb1.5 (2/16)
YSLFGG KNIQYFGAGTRLSVL Jb2.4 (3/16)
DWTSGV YEQYFGPGTRLTVT Jb2.7 (7/16)
SQGRP YGYTFGSGTRLTVV Jb1.2 (4/16)
Patient 4 ERSYSRLV NEQFFGPGTRLTVL Jb2.1 (2/27)
EIQTAGT YEQYFGPGTRLTVT Jb2.7 (4/27)
DWTSGV YEQYFGPGTRLTVT Jb2.7 (6/27)
EPGHGDYEQYFGPGTRLTVT Jb2.7 (1/27)
DRTGGT YEQYFGPGTRLTVT Jb2.7 (1/27)
SVYFCASR WGSK NTGELFFGEGSRLTVL Jb2.2 (3/27)
VFTGSP YEQYFGQGTRLTVL Jb2.7 (1/27)
KLAHLT YEQYFGPGTRLTVT Jb2.7 (1/27)
YGF SGNTIYFGEGSWLTAV Jb1.3 (6/27)
NGF SGNTIYFGEGSWLTVV Jb1.3 (1/27)
LPGSGKK YFGPGTRLTVT Jb2.7 (1/27)
Patient 5 AKFTLVG NQPQHFGDGTRLSIL Jb1.5 (2/26)
SFEGAP YNEQFFGPGTRLTVL Jb2.1 (1/26)
DWTSGV YEQYFGPGTRLTVT Jb2.7 (3/26)
SVYFCASI LTGARTGELFFGEGSRLTVL Jb2.2 (3/26)
WGSK NTGELFFGEGSRLTVL Jb2.2 (9/26)
SVYFCASR SLEGI SYEQYFGPGTRLTVT Jb2.7 (1/26)
DGGGG SYEQYFGPGTRLTVT Jb2.7 (1/26)
SAIM NTEAFFGQGTSITVV Jb1.1 (1/26)
SVYFCASR DPRN QETQYFGPGTRLLVL Jb2.5 (1/26)
SKGRGNTIYFGEGTWLTVV Jb1.3 (1/26)
AGY NEQLLGPGTRLTVL Jb2.1 (2/26)
Patient 6 SVYFCASY YGRLS SYNSPLHFGDGTRLTVT Jb1.6 (9/37)
YEGHPP YNEQFFGPGTRLTVL Jb2.1 (6/37)
YASGI AKNIQYFGAGTRLSVL Jb2.4 (2/37)
DWYSGV YEQYFGPGTRLTVT Jb2.7 (1/37)
DWTSGV YEQYFGPGTRLTVT Jb2.7 (2/37)
YVASGK ETQYFGPGTRLLVL Jb2.5 (1/37)
ELAGG YNEQFFGPGTRLTVL Jb2.1 (4/37)
PWRGDD NEQFFGPGTRLTVL Jb2.1 (4/37)
RASG QETQYFGPGTRLLVL Jb2.5 (2/37)
SVYFCASH YGF SGNTIYFGEGSWLTAV Jb1.3 (1/37)
SGVQG TQYFGPGTRLTVL Jb2.3 (1/37)
SVYFCASN ESGVYE QYFGPGTRLTVT Jb2.3 (2/37)
The nomenclature used here is in accord with the MGTdatabase, http://imgt.cnusc.fr:8104 (Ruiz et al, 2000).
COMMONLY USED CDR3 OF TCR bCHAIN IN PSORIASIS 361VOL. 120, NO. 3 MARCH 2003
degree of CDR3 heterogeneity in the individual bands, and to
identify TCR b-chain gene families containing repetitive TCR
VDJ rearrangements, each band was excised, cloned, and
subsequently sequenced. Amino acid sequences were deduced
from the nucleotide sequence of the CDR3 regions and only
functional in-frame TCR rearrangements were utilized. Various
TCRVb rearrangements in psoriatic lesions were observed; the
results are given in Tables I and II. Remarkably, all the patients
examined contained an identical CDR3 motif on the TCR
b-chain, Vb13-DWTSGV-Jb2.7. In some patients, the transcripts
containing Vb13 contained a common amino acid sequence on
the CDR3 region: YGF-Jb1.3 (four of six patients examined),
WGSK-Jb2.2 (three of six),YASGI-Jb2.4 (three of six), PRGGW-
Jb2.4 (two of six), and YSLFGG-Jb2.4 (two of six) (Table I).
Upon examination of Vb15, however, we were not able to
detect a common CDR3 sequence as with Vb13 except for
homologous amino acid composition (D, L, G, A, or R) in
CDR3 as shown inTable II.
Detection of theVb13-DWTSGV-Jb2.7 motif on skin biopsies
(lesional and nonlesional) from psoriasis patients and
healthy individuals To examine the in¢ltration of T cells
with the common CDR3 sequence (Vb13-DWTSGV-Jb2.7, also
designated the CDR3 motif) in psoriatic lesions, we used the
detection system described in Materials and Methods. As shown in
Fig 2, the CDR3 motif was highly expressed in lesions from
the psoriasis patients examined (n¼ 7) compared to healthy
individuals (n¼ 6), which showed a weak expression.
Then, we screened more patients to compare the expression of
the CDR3 motif between the lesions and nonlesional skin
derived from psoriasis patients. Of the patients examined
(n¼15), the expressions of the CDR3 motif were increased in
lesions derived from 11 patients compared to those in
nonlesional skin, although a quantitative variation among the
patients was noted (patients 17 and 21 showed slightly increased
expressions in lesions compared to nonlesional skin), three
patients showed decreased expression in lesions compared to
nonlesional skin, and one patient showed no di¡erence in
expression between lesional and nonlesional skin (Fig 3 and
Table III).
Detection of Vb13-DWTSGV-Jb2.7 motif in PBMC and CLAþ
cells from psoriasis patients and healthy individuals We
examined whether the speci¢c CDR3 motif could be detected
in PBMC from psoriasis patients or not. As shown in Fig 4(A),
the Vb13-DWTSGV-Jb2.7 motif was detected in PBMC from
psoriasis patients (n¼ 7). Of note was that this speci¢c motif
was detected in PBMC from healthy individuals (n¼ 3) as well
as in PBMC from psoriasis patients. Then, we examined
whether T cells with Vb13-DWTSGV-Jb2.7 in PBMC were
associated with the CLA, which is widely accepted to act as a
skin-selective homing antigen. We conducted RT-PCR with
puri¢ed CLAþ cells from PBMC from psoriasis patients (n¼ 5)
Table II. TCRVDJ region sequences of in¢ltrating Tcells withVb15 in the psoriatic lesions from six patients
Patient Vb15 NDN J region Constant region Nomenclature and frequency
Patient 1 ALYFCATS AVS SYNEQFFGPGTRLTVL EDLNKVFPPEV Jb2.1 (3/5)
D QYFGPGTRLLVL Jb2.5 (1/5)
GDREET QYFGPGTRLLVL Jb2.5 (1/5)
Patient 2 DLGAGGLYNEQFFGPGTRLTVL Jb2.1 (1/9)
DAGFAS QETQYFGPGTRLLVL Jb2.5 (1/9)
KAGLASD EQFFGPGTRLTVL Jb2.1 (1/9)
DGGSPPN TQYFGPGTRLTVL Jb2.3 (2/9)
VLTGG YNEQFFGPGTRLTVL Jb2.1 (1/9)
DQPGE GYTFGSGTRLTAV Jb1.2 (2/9)
VSD QPQHFGDGTRLSIL Jb1.5 (1/9)
Patient 3 DLADSATDTQYFGPGTRLTVL Jb2.3 (2/5)
DLRTG TDTQYFGPGTRLTVL Jb2.3 (2/5)
DLADSTD TQYFGPGTRLLVL Jb2.5 (1/5)
Patient 4 GRTSGGN QETQYFGPGTRLLVL Jb2.5 (3/10)
DLAGGQYNEQFFGPGTRLTVL Jb2.1 (1/10)
DLAGRAPD EQFFGPGTRLTVL Jb2.1 (1/10)
EGGGRAYNEQFFGPGTRLTVL Jb2.1 (1/10)
DRRE NSPLHFGNGTRLTVL Jb1.6 (2/10)
ALYFCATP GDRE ETQYFGPGTRLLVL Jb2.5 (2/10)
Patient 5 DLGAGGLYNEQFFGPGTRLTVL Jb2.1 (2/9)
DQRGGNQ ETQYFGPGTRLLVL Jb2.5 (1/9)
DRTT YNEQFFGPGTRLTVL Jb2.1 (4/9)
DQG SYEQYFGPGTRLTVT Jb2.7 (1/9)
AG YGYTFGSGTRLTVV QDLKNVFPPEV Jb1.2 (1/9)
Patient 6 DRLGGSK TQYFGPGTRLLVL Jb2.5 (3/8)
DSGTRE YEQYFGPGTRLTVT Jb2.7 (2/8)
ALYFCATG SGYG TGELFFGEGSRLTVL Jb2.2 (3/8)
Figure 2. Detection of the CDR3 motif (Vb13-DWTSGV-Jb2.7) in
skin biopsies derived from seven psoriasis patients (patients 713)
and six healthy individuals (H1H8). cDNAwas prepared from total
RNA from 2 mm skin biopsies by reverse transcription and normalized
with GAPDH. Normalized cDNAwas ¢rst ampli¢ed using Vb13 primer
and Cb3 primer. The second round PCR was conducted using oligonu-
cleotide corresponding to DWTSGV-Jb2.7 and Cb3 for CDR3, and Cb2
and Cb3 primer for the constant region as internal control, respectively.
The PCR products were separated on a 1.3% agarose gel and transferred
to a positively charged nylon membrane and covalently ¢xed by ultraviolet
light. Then, the membrane was prehybridized, and hybridized with 32P-
radiolabeled oligonucleotide probe corresponding to the Vb13-DWTSGV-
Jb2.7 at 561C and Cb5 speci¢c for the constant region at 441C. After wash-
ing, the membrane was analyzed after exposure on X-ray ¢lm.
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and healthy individuals (n¼ 3). CLAþ cells from PBMC of
psoriasis patients showed a higher expression of Vb13-
DWTSGV-Jb2.7 motif compared to those of healthy individuals
as in the case of skin (Fig 4B).
DISCUSSION
Psoriasis is an in£ammatory skin disease, and recent observations
suggest that it is aT-cell-mediated immune response (Bos and De
Rie, 1999; Prinz, 1999). T cells bearing the common CDR3 motif
in their receptor would recognize psoriasis-related antigen and/or
contribute to a critical component in the development of psoria-
sis. In this study, we have identi¢ed a common CDR3 motif of
TCR in lesions from psoriasis patients by PCR-based spectratyp-
ing and subsequent sequencing.
Results shown here provide several issues to elucidate the role
of T cells in¢ltrating psoriatic lesions. First, the experimental ap-
proaches described above allowed the identi¢cation of a speci¢c
Vb13-DWTSGV-Jb2.7 motif in psoriatic lesions. Second, the ob-
servation that CDR3 inTCRVb15 consists of identical or highly
homologous amino acids is in agreement with the results by
Prinz et al (1999), where the CDR3 of TCR b-chain of several
clonally expanded T cells in psoriatic lesions was shown to be
composed of the amino acid motif GLA (Prinz et al, 1999). Third,
it was intriguing to note that the common motif was observed in
the nonlesional skin of psoriasis patients as well as lesions. The
symptomless skin of psoriasis patients may respond to an injury
with the appearance of a psoriatic lesion, a phenomenon called
K˛bner response (K˛bner, 1878). The response is one of the most
characterized manifestations, which is capable of explaining the
induction of psoriasis in nonlesional skin from psoriasis patients.
It has been reported that T cells are involved in this response,
although it is unclear which type of T cells is directly associated
with the K˛bner response (Baker et al, 1988). In this regard, we
may hypothesize that the in¢ltrating T cells bearing this con-
served CDR3 motif in nonlesional skin of psoriasis patients
might be involved in the K˛bner response. Fourth, CLAþ T cells
with the Vb13-DWTSGV-Jb2.7 motif in peripheral blood from
psoriasis patients were abundant. Several reports have suggested
that the initiation or exacerbation of psoriasis is associated with
infection by group A streptococci (Davison et al, 1999; Skov and
Baadsgaard, 2000). In many cases of autoimmune diseases, in fact,
the similarities between infectious pathogens and self-antigens
may lead to inadvertent auto-sensitization in the course of an im-
mune response to microbes (Torres and Johnson, 1998). Therefore,
we may speculate that CLAþ T cells containing the speci¢c
CDR3 motif in peripheral blood of psoriasis patients may be-
come activated by stimulator(s) or some pathogen(s) and then
the expanded CLAþ Tcells may be involved in the development
of psoriatic lesions. Finally, the results from this study could help
Figure 3. Detection of the CDR3 motif Vb13-DWTSGV-Jb2.7 in
skin biopsy specimens of nonlesional skin (N) and psoriatic lesional
skin (L) derived from psoriasis patients. Skin biopsies obtained from
15 psoriasis patients (patients 1428) were analyzed under the same condi-
tions as described in Fig 2.
Table III. Expression of the CDR3 motif in psoriatic lesions
and nonlesional skin relative to the expression of the constant
region of the TCR b-chain
Patient Biopsies Ratio
14 N 0.69
L 1.38
15 N 0.57
L 1.03
16 N 0.8
L 1.85
17 N 1.07
L 1.45
18 N 1.53
L 0.95
19 N 2.26
L 1.18
20 N 1.34
L 3.00
21 N 1.47
L 1.76
22 N 1.21
L 2.11
23 N 0.74
L 3.03
24 N 2.57
L 2.26
25 N 2.05
L 3.5
26 N 1.51
L 0.98
27 N 1.25
L 2.28
28 N 1.09
L 3.13
Figure 4. Detection of the CDR3 motif (Vb13-DWTSGV-Jb2.7) in
PBMC and in CLAþ cells from psoriasis patients and healthy indi-
viduals. PBMC was isolated from heparinized blood by density centrifu-
gation using Ficoll-Hypaque. CLAþ cells were puri¢ed from PBMC by
the magnetic cell separation method as described in Materials and Methods.
The existence of the speci¢c CDR3 motif in PBMC obtained from seven
patients with psoriasis (patients 2228) and three healthy individuals
(H1H3) was analyzed, and in CLAþ cells from ¢ve patients with psoria-
sis (patients 2933) and three healthy individuals (H4H6) as previously
mentioned. NC means negative control and PC means positive control.
(A) Detection of the CDR3 motif in PBMC and (B) detection of the
CDR3 motif in CLAþ cells.
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in providing a potential clinical application in psoriasis. The com-
mon CDR3 motif may be used as a speci¢c marker for monitor-
ing the disease, and a peptide-bound TCR containing a common
CDR3 motif may have great potential for eliciting anti-idiotypic
T cells byT cell vaccination in psoriasis patients (Zipp et al, 1998;
Matsumoto et al, 2000; Zang et al, 2000).
Various studies have demonstrated that repetitiveTCR rearran-
gements in in£ammatory T cells seem to represent clonally ex-
panded T cells that have proliferated by antigen-induced
stimulation (Oksenberg et al, 1993; Mantegazza et al, 1993; Matsu-
moto et al, 1996; Hong et al, 1999). Although the TCR repertoires
selected by de¢ned antigen major histocompatibility complexes
may be heterogeneous, a conserved TCR rearrangement was
identi¢ed in several autoimmune diseases. The persistence of T
cells containing the identical and/or highly homologous CDR3
region in psoriatic lesions is considered to re£ect the presence of
a common disease-associated antigen, and the activation of Tcells
containing the motif is likely to be involved in the initiation and
maintenance of the immune response required for the pathologic
features of psoriasis (Lin et al, 2001;Vollmer et al, 2001).
Psoriasis is associated with particular HLA alleles such as Cw6,
B13, BW53, and DRBn07 (Kim et al, 2000; Elder et al, 2001).
Therefore, we analyzed HLA alleles of several patients.We could
not ¢nd an association between the expression of the identi¢ed
CDR3 motif and speci¢c HLA alleles, however, especially in
accordance with Cw6 (data not shown). Recently, genome-wide
scans have provided evidence for linkage of psoriasis not only to
HLA but also to several non-HLA loci such as the HLA-linked
locus (PSORS1) and corneodesmosin (CDSN) (Haftek et al,
1997;Trembath et al, 1997;Veal et al, 2001).The association between
the identi¢ed CDR3 motif in Korean psoriasis patients and other
HLA loci (HLA-A, HLA-B, HLA-DR, etc.) as well as non-HLA
loci remains to be investigated in further study.
In summary, we found a T cell population with a speci¢c
CDR3 motif (Vb13-DWTSGV-Jb2.7 motif) to be in¢ltrated in
CLAþ cells in PBMC as well as in lesions from psoriatic patients,
and in¢ltrated T cells with Vb15 in psoriatic lesions were
shown to contain identical or highly homologous amino acid
compositions in their CDR3 region. These results suggest that
the in¢ltrated Tcells with the identi¢ed CDR3 motif in psoriasis
patients may be involved in psoriasis pathogenesis. In addition,
the strategy employed in this study provides insights into the
pathomechanism of the disease and further provides a systemic
therapeutic strategy for psoriasis.
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